1. Brrusselle GG, Kooppelman GH. Biologic Therapies for Severe Asthma. N Engl J Med. 2022;386(2):157-71.
2. Beasley R, Hancox R. Reducing the burden of asthma: time to set research and clinical priorities. Lancet Respir Med. 2020;8(10):943-4.
3. Sucai L, Mukesh V, Lidia M, Weimin L, Anand S, Donald R, et al. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin. J Allergy Clin Immunol. 2018;141(1):257-68 e6.
4. Steven L, Lex E X Leong, Jocelyn M, Steve V, Ian A Yang, John W Upham, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018;141(1): 94-103 e15.
5. Laurits F, Alexander S. The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2021;9(3):1267-75.
6. Ling-Bo Li, Donald Y M Leung, Elena G. Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatic. PLoS One. 2015;10(10):e0141909.
7. Southworth T, Manson S, Bell A. PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge. Biomark Res. 2018;6(14).
8. Mcmillan J, Xanthou G, Lloyd M. Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy. 2005;35(3):388-96.
9. Finott S, Sanctis G, Leher H. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med, 2001, 193(11): 1247-60.
10. Hualiang J, Cui C, Bei L, Weizhong J, Junbo X, Limin W, et al. Modified Si-Jun-Zi-Tang Attenuates Airway Inflammation in a Murine Model of Chronic Asthma by Inhibiting Teff Cells via the mTORC1 Pathway. Front Pharmacol. 2019;10(161).
11. Bailey MT, Kierstein S, Sharma S. Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J Immunol. 2009;182(12):7888-96.
12. Li J, Hlavka J, Shrimp H. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. Cancer Discov, 2021, .
13. Chung KF. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest. 2011;139(6):1470-9.
14. Zhang Y, Leung DY, Goleva E. Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma. J Allergy Clin Immunol. 2014;133(6):1744-52 e1.
15. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905-17.
16. Gaetano C, Francesco N, Sharon M, Federica Lo Bell. Corticosteroid resistance in asthma: Cellular and molecular mechanisms. Mol Aspects Med. 2021;100969.
17. Rana M, Simon R, Hannah J, Dave S, et al. Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi. Respir Res. 2017;18(1):61.
18. Simon L , Jian L, Jonathan P. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells. J Mol Med (Berl). 2020;98(3):361-74.